Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2006 Oct;449(4):395-401.
doi: 10.1007/s00428-006-0250-1. Epub 2006 Sep 12.

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

G Rindi  1 , G Klöppel, H Alhman, M Caplin, A Couvelard, W W de Herder, B Erikssson, A Falchetti, M Falconi, P Komminoth, M Körner, J M Lopes, A-M McNicol, O Nilsson, A Perren, A Scarpa, J-Y Scoazec, B Wiedenmann; all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS)
Affiliations
Practice Guideline

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

G Rindi et al. Virchows Arch. 2006 Oct.

Abstract

The need for standards in the management of patients with endocrine tumors of the digestive system prompted the European Neuroendocrine Tumor Society (ENETS) to organize a first Consensus Conference, which was held in Frascati (Rome) and was based on the recently published ENETS guidelines on the diagnosis and treatment of digestive neuroendocrine tumors (NET). Here, we report the tumor-node-metastasis proposal for foregut NETs of the stomach, duodenum, and pancreas that was designed, discussed, and consensually approved at this conference. In addition, we report the proposal for a working formulation for the grading of digestive NETs based on mitotic count and Ki-67 index. This proposal, which needs to be validated, is meant to help clinicians in the stratification, treatment, and follow-up of patients.

PubMed Disclaimer

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1053/j.gastro.2005.01.058', 'is_inner': False, 'url': 'https://doi.org/10.1053/j.gastro.2005.01.058'}, {'type': 'PubMed', 'value': '15887103', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15887103/'}]}
    2. Anlauf M, Perren A, Meyer CL, Schmid S, Saremaslani P, Kruse ML, Weihe E, Komminoth P, Heitz PU, Klöppel G (2005) Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 128:1187–1198 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/01.pas.0000151617.14598.ae', 'is_inner': False, 'url': 'https://doi.org/10.1097/01.pas.0000151617.14598.ae'}, {'type': 'PubMed', 'value': '15767809', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15767809/'}]}
    2. Anlauf M, Wieben D, Perren A, Sipos B, Komminoth P, Raffel A, Kruse ML, Fottner C, Knoefel WT, Monig H, Heitz PU, Klöppel G (2005) Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol 29:524–533 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16334127', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16334127/'}]}
    2. Artale S, Giannetta L, Cerea G, Pedrazzoli P, Schiavetto I, Napolitano M, Veronese S, Bramerio E, Gambacorta M, Vanzulli A, Pisconti S, Pugliese R, Siena S (2005) Treatment of metastatic neuroendocrine carcinomas based on WHO classification. Anticancer Res 25:4463–4469 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/annonc/mdi258', 'is_inner': False, 'url': 'https://doi.org/10.1093/annonc/mdi258'}, {'type': 'PubMed', 'value': '15939719', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15939719/'}]}
    2. Bajetta E, Catena L, Procopio G, Bichisao E, Ferrari L, Della Torre S, De Dosso S, Iacobelli S, Buzzoni R, Mariani L, Rosai J (2005) Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol 16:1374–1380 - PubMed
    1. None
    2. DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) World Health Organization classification of tumours, pathology and genetics of tumours of endocrine organs. IARC, Lyon

Publication types

MeSH terms

Substances

LinkOut - more resources